We are live on
!
Find out more
First Merchants Corp Portfolio holdings
AUM
$3.05B
Turnover
4.86%
1-Year Est. Return
11.62%
This Fund
S&P 500
This Quarter
Est. Return
+10.71%
1 Year Est. Return
+11.62%
3 Year Est. Return
+55.61%
5 Year Est. Return
+63.63%
10 Year Est. Return
+228.04%
AUM
$1.22B
AUM Growth
+$98.3M
(+8.8%)
Cap. Flow
-$12.1M
Cap. Flow
% of AUM
-0.99%
Top 10 Holdings %
Top 10 Hldgs %
26.58%
Holding
214
New
10
Increased
73
Reduced
103
Closed
3
Avg Time Held
6.4
years
Top 10 Avg Time Held
3.1
years
Top 20 Avg Time Held
3.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$3.76M |
| 2 |
Amazon
AMZN
|
+$1.17M |
| 3 |
Ametek
AME
|
+$1.14M |
| 4 |
McDonald's
MCD
|
+$1.07M |
| 5 |
Walmart Inc
WMT
|
+$1.02M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$3.71M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$3.21M |
| 3 |
PepsiCo
PEP
|
+$2.93M |
| 4 |
T. Rowe Price
TROW
|
+$2.62M |
| 5 |
Emerson Electric
EMR
|
+$2.22M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 37.34% |
| 2 | Technology | 18.52% |
| 3 | Healthcare | 10.19% |
| 4 | Financials | 8.01% |
| 5 | Consumer Discretionary | 6.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
CVS Health
CVS
$118B
| $1.8M | 0.15% |
22,791
-14,627
| -39% | -$1.04M |
2017 Q3
25 quarters
|
|
127
Phillips 66
PSX
$117B
| $1.79M | 0.15% |
13,472
-505
| -4% | -$60.4K |
2016 Q4
28 quarters
|
|
128
Casey's General Stores
CASY
$25.5B
| $1.79M | 0.15% |
6,503
-231
| -3% | -$63.2K |
2017 Q3
25 quarters
|
|
129
iShares MSCI Emerging Markets ETF
EEM
$29.1B
| $1.78M | 0.15% |
44,322
+4,184
| +10% | +$162K |
2019 Q3
17 quarters
|
|
130
American Tower
AMT
$86.3B
| $1.66M | 0.14% |
7,669
-1,625
| -17% | -$307K |
2019 Q2
18 quarters
|
|
131
Roper Technologies
ROP
$37.9B
| $1.61M | 0.13% |
2,945
-153
| -5% | -$78.8K |
2019 Q4
16 quarters
|
|
132
Alexandria Real Estate Equities
ARE
$7.16B
| $1.6M | 0.13% |
12,594
+963
| +8% | +$104K |
2020 Q3
13 quarters
|
|
133
Oracle
ORCL
$389B
| $1.57M | 0.13% |
14,872
+940
| +7% | +$103K |
2013 Q2
42 quarters
|
|
134
Vanguard Morningstar Large-Cap ETF
VV
$54.2B
| $1.41M | 0.12% |
6,446
-1,000
| -13% | -$204K |
2017 Q3
25 quarters
|
|
135
iShares Biotechnology ETF
IBB
$10.3B
| $1.4M | 0.11% |
10,283
-39
| -0.4% | -$4.76K |
2013 Q2
42 quarters
|
|
136
iShares Core S&P 500 ETF
IVV
$880B
| $1.38M | 0.11% |
2,882
-68
| -2% | -$30.4K |
2016 Q2
30 quarters
|
|
137
J.M. Smucker
SJM
$13.6B
| $1.37M | 0.11% |
10,858
-1,766
| -14% | -$205K |
2013 Q2
42 quarters
|
|
138
Vanguard FTSE All-World ex-US ETF
VEU
$67B
| $1.37M | 0.11% |
24,400
| – | – |
2013 Q2
42 quarters
|
|
139
Jack Henry & Associates
JKHY
$10.7B
| $1.34M | 0.11% |
8,217
-337
| -4% | -$51.6K |
2013 Q2
42 quarters
|
|
140
Deere & Co
DE
$173B
| $1.33M | 0.11% |
3,327
+2,058
| +162% | +$776K |
2020 Q3
13 quarters
|
|
141
Coca-Cola
KO
$404B
| $1.33M | 0.11% |
22,495
-1,141
| -5% | -$64.8K |
2013 Q2
42 quarters
|
|
142
SiteOne Landscape Supply
SITE
$4.14B
| $1.28M | 0.1% |
7,848
-6,407
| -45% | -$934K |
2019 Q3
17 quarters
|
|
143
Huntington Bancshares
HBAN
$30.9B
| $1.21M | 0.1% |
94,895
+44,987
| +90% | +$492K |
2023 Q3
1 quarter
|
|
|
144
Pfizer
PFE
$169B
| $1.14M | 0.09% |
39,547
-122,715
| -76% | -$3.71M |
2013 Q2
42 quarters
|
|
145
U.S. Core Equity 2 Portfolio ETF Class Shares
DFAC
$48.8B
| $1.12M | 0.09% |
38,487
| – | – |
2022 Q4
4 quarters
|
|
146
Nike
NKE
$55.1B
| $1.12M | 0.09% |
10,306
-512
| -5% | -$55K |
2017 Q3
25 quarters
|
|
147
Ecolab
ECL
$81B
| $1.09M | 0.09% |
5,497
-105
| -2% | -$18.9K |
2013 Q2
42 quarters
|
|
148
iShares MSCI EAFE ETF
EFA
$76.9B
| $1.07M | 0.09% |
14,209
+9,502
| +202% | +$672K |
2016 Q2
30 quarters
|
|
149
Schwab US TIPS ETF
SCHP
$16.4B
| $970K | 0.08% |
+37,160
| New | +$945K |
2023 Q4
0 quarters
|
|
150
La-Z-Boy
LZB
$1.2B
| $841K | 0.07% |
22,794
+232
| +1% | +$7.47K |
2019 Q3
17 quarters
|
|
Similar funds
CFM
JFGIW
SL
First Merchants Corp's Q4 2023 Portfolio in Review
As of Q4 2023, First Merchants Corp held 214 positions worth $1.22B, up 8.8% from $1.12B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
First Merchants Corp's Q4 2023 filing shows 10 new, 73 increased, 103 reduced and 3 closed positions. Its largest new stake was AstraZeneca: 28,895 shares worth $3.89M. The largest sale was Pfizer, an estimated $3.71M.
By sector, the portfolio is most concentrated in Miscellaneous at 37% of assets, down from 38% a quarter earlier, followed by Technology and Healthcare.
- First Merchants Corp's largest Q4 2023 buy was AstraZeneca: 28,895 shares worth $3.89M.
- First Merchants Corp added most to Amazon in Q4 2023, an estimated $1.17M increase.
- First Merchants Corp's biggest Q4 2023 reduction was Pfizer, cutting an estimated $3.71M.
- First Merchants Corp fully exited Northern Trust in Q4 2023, selling an estimated $792K.
- First Merchants Corp's ten largest holdings make up 27% of its $1.22B portfolio in Q4 2023.
- First Merchants Corp opened 10 new positions and closed 3 in Q4 2023.
- First Merchants Corp's portfolio value rose 8.8% quarter-over-quarter to $1.22B.
Based on First Merchants Corp's 13F filing for Q4 2023, filed 25 Jan 2024.